PATENT CLAIM ANALYSIS

Application Number: 16084308
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "495000"]

Abstract:
A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly indicated for the administration to patients once or twice a day and it can be used also for pediatric administration.

Claim (Index 6):
The dosage form according to  claim 1 , wherein the plasticizer is selected from the group consisting of propylene glycol, triethyl citrate, acetyl tributyl citrate, acetyl triethyl citrate, benzyl benzoate, ricin oil, chlorbutanol, diacetyl monoglycerides, dibutyl sebacate, diethyl phthalate, glycerine, mannitol, polyethylene glycol, polyethylene glycol monomethyl ether, pullulan, sorbitol, sorbitol sorbitan solution, triacetin, tributyl citrate, and vitamin E.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15238037', '12835863', '13126236', '11669630', '15172955']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7421541024575238
- 35 USC 102 Novelty (BERT): 0.4554380543513627
- Combined Prediction Score: 0.7134824976469076
- Mean Citation Score: 172.02167
- Max Citation Score: 176.6465
- Similarity Product: 154.47371710529924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test